Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Nova-Cure AS
AS
Active
Org 915719139
Torggata 1, 2317
Hamar
General medical practice activities
·
NACE 8621
Est. 2015 · 10 years old
2 employees
Monitor
Share
Norway
/
Companies
/
General medical practice activities
/
Nova-Cure AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AT
Abdisa Tamirat Adugna
Chief Executive Officer
Chief Executive Officer
2026
Former (2)
SK
Sigrid Kristine Sele Haugtomt
Chief Executive Officer
Chief Executive Officer
2024 – 2026
LW
Lars Wefring
Chief Executive Officer
Chief Executive Officer
2015 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
AT
Abdisa Tamirat Adugna
Chairman
Chairman
2026
Former (4)
SK
Sigrid Kristine Sele Haugtomt
Chairman
Chairman
2024 – 2026
LW
Lars Wefring
Chairman
Chairman
2021 – 2024
SH
Stefan Haugtomt Haug
Board of Directors
Board of Directors
2025 – 2026
IE
Inger Eline Wetten Tjønneland
Board of Directors
Board of Directors
2015 – 2021
Shareholders
As of last annual report
Adugna Holding As — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Adugna Holding As
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Nova-Cure AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network